Related Experiment Video
Updated: May 18, 2026
Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents
Published on: August 16, 2024
Cryptococcus detection technologies: An overview of conventional, immunological, and molecular methods, and future
Ziqi Zhao1, Simeng Zhang2, Yemei Huang3
1Department of Respiratory and Critical Care, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Abstract:
Cryptococcus, notably Cryptococcus neoformans and Cryptococcus gattii, is a pathogenic fungus that poses a significant threat to global health. Early and rapid detection is pivotal for reducing mortality, yet conventional diagnostic techniques suffer from inherent limitations-including slow turnaround times, low sensitivity in early infection, and heavy reliance on specialized expertise-that delay clinical intervention. Advancements in detection technology have established immunological and molecular methods as essential tools for identifying Cryptococcus. This review moves beyond descriptive summary to provide a critical analytical evaluation of conventional (microscopy, histopathology, fungal culture), immunological (ELISA, LAT, LFA), and molecular (PCR variants, isothermal amplification, NGS) detection technologies, with a focus on dissecting the mechanistic drivers of performance variability, technical bottlenecks, and practical limitations across clinical scenarios. Among them, the lateral flow assay and isothermal amplification are particularly notable for their simplicity, speed, efficiency, and low cost. These integrated systems have the potential to overcome the limitations of single-method approaches, enabling simultaneous antigen screening, species identification, and fungal load quantification to support precise, timely antifungal therapy in both resource-rich and resource-limited settings.
Insights
Rapid detection of Cryptococcus fungal infections is crucial for patient survival. This review highlights advanced immunological and molecular diagnostic methods, like lateral flow assays and isothermal amplification, for faster and more accurate identification.
Area of Science:
- Mycology
- Infectious Diseases
- Diagnostic Technologies
Background:
- Cryptococcus species (e.g., Cryptococcus neoformans, Cryptococcus gattii) are significant global health threats.
- Current diagnostic methods for Cryptococcus infections are often slow, lack sensitivity, and require specialized expertise, delaying critical clinical interventions.
Purpose of the Study:
- To critically evaluate conventional, immunological, and molecular diagnostic technologies for Cryptococcus detection.
- To analyze performance variability, technical bottlenecks, and limitations of these methods in various clinical settings.
Main Methods:
- Review of conventional methods (microscopy, histopathology, fungal culture).
- Analysis of immunological assays (ELISA, LAT, LFA).
- Evaluation of molecular techniques (PCR variants, isothermal amplification, NGS).
Main Results:
- Conventional methods have limitations in speed and sensitivity.
- Immunological and molecular methods offer improved detection capabilities.
- Lateral flow assays (LFA) and isothermal amplification show particular promise due to simplicity, speed, efficiency, and low cost.
Conclusions:
- Integrated diagnostic systems combining antigen screening, species identification, and fungal load quantification are needed.
- Advanced methods like LFA and isothermal amplification can overcome limitations of traditional techniques.
- These technologies can facilitate precise, timely antifungal therapy in diverse healthcare settings.
Related Concept Videos
01:28Methods of Classification and Identification
01:30Methods to Assess Microbial Populations
01:24Automated Microbial Diagnostics